Venezia Italy, Hilton Molino Stucky 13/16 March

Comments

Transcription

Venezia Italy, Hilton Molino Stucky 13/16 March
Venezia Italy, Hilton Molino Stucky
13/16 March 2013
advanced programme
1
S
Scientific Secretariat
Organizing Secretariat
Congress Website
T.+39 050503985
[email protected]
Biomedical Technologies srl
www.biomedicaltechnologies.com
Main Office and Accounting Department
Via P. Cugia 1 – 09129 Cagliari – Italy
T. +39 070340293 – F. +39 070307727
[email protected]
Marketing Office
Via Metauro 19-00198 Roma – Italy
T. +39 068546198 F. +39 0685389063
[email protected]
www.humanrep2013.com
secretariats
A
The Academy
President
Joseph G. Schenker (IL)
Executive
Liselotte Mettler (D)
Andrea R. Genazzani (I)
John Sciarra (USA)
Active Fellows
Barri Pedro N. (ES)
Benagiano Giuseppe (I)
Beier Henning M. (D)
Ben-Rafael Zion, (IL)
Birkhäuser Martin (CH)
Coutifaris Christos (USA)
Creatsas George K., (GR)
Devoto Luigi C., (RCH)
Diedrich Klaus (D)
Di Renzo Gian Carlo (I)
Gomel Victor (CDN)
Holzgreve Wolfgang (CH)
Khomassuridze Archil (GE)
Klimek Rudolf, (PL)
Kovacs Gabor T (AUS)
Kurjak Asim, (HR)
Laufer Neri (IL)
Naftolin Frederick (USA)
Patrizio Pasquale (USA)
Seppala Markku T (FIN)
Shoham Zeev (IL)
Strauss Jerome F. III (USA)
Tan Seang L. (CDN)
Trounson Alan (AUS)
Vartej Petrache (RO)
P
Past congresses
1st 1974 Rio de Janeiro, Brazil
2nd 1979 Tel Aviv, Israel
3rd 1981 Berlin, Germany
4th 1983 Bombay, India
5th 1985 Athens, Greece
6th 1987 Tokyo, Japan
7th 1990 Helsinki, Finland
8th 1993 Bali, Indonesia
9th 1996 Philadelphia, USA
10th 1999 Salvador, Brazil
11th 2002 Montreal, Canada
12th 2005 Venice, Italy
13th 2009 Venice, Italy
14th 2011 Melbourne, Australia
Honorary Fellows
Fathalla Mahmoud (ET)
Frydman Rene (F)
Poster Session
Official Language
CME Accreditation
Official Invitation
The Poster Session will
take place on March 13th
from 18.00 to 20.00.
Poster Authors should
stand by their Posters
for presentation and
discussion.
English is the official
language of the Congress.
Italian courses will be
organized.
The scientific programme
will be submitted for
accreditation by UEMS
The Official Letter
of Invitation can be
printed from your
personal area in the
congress website.
This invitation implies
no obligation, financial
or otherwise, by the
Congress.
2
Joseph G. Schenker
President International
Academy of Human
Reproduction
Andrea Riccardo Genazzani
Chairman of the congress
Dear Friends
As President of the International Academy of Human Reproduction it is my pleasure to invite you to the 15th World Congresses
organized by Professor Andrea Genazzani in Venice in 2013.
Since the establishment of the Academy by our late friend the
distinguished Brazilian gynecologist, A. Campus De Paz, we had
14 World Congresses and I think the list is quite impressive.
The World Congress became most significant venue for the
scientific exchange in human reproduction, with high quality of
papers and debates. A truly international gathering of scientists
and clinicians who are working in their respective countries to
advance our collaborative agenda and making progress in the
science of human reproduction.
In 2011 we have taken another step in developing a sustained
Academy under the name of “International Academy of Human
Reproduction -IAHR-” a no-profit association governed by 60
articles of our association and following of the Swiss Civil Code,
was registered in Lucarno (Switherland).
The main objectives of IAHR are:
I. To extend the knowledge in all aspects of human reproduction, fertility and infertility, and family planning, as well as
population affairs.
II. To encourage exchange of clinical experience and promote
scientific thought and investigation.
III. To consider ethical and social implications of the current
practice of human reproduction and reproductive biology.
The Fellows of the Academy are selected among those applicants from the fields of clinical medicine, medical and biological sciences, and other fields related to reproductive health and
medicine.
Fellows are elected on basis of their singular and significant contributions to the field and they must be acknowledged as world
leaders in their discipline.
Since the last Congress we organized in Melbourne several
meaningful developments occurred in our field, which we shall
be happy to hear about throughout the scientific program in
Venice 2013.
The 2013 Congress will promote excellence in reproduction
and aim to bridge gaps between the expansion of information
and its implementation in clinical practice.
The advances in technology and scientific knowledge have
created new ethical dilemmas, which may influence societies
around the world. These will be broadly discussed.
I look forward to see you in the romantic city of Venice, “city of
water, masks and bridges” sharing with you the most pressing
issues facing clinicians and scientist in the field of reproduction today.
Dear friends and colleagues,
According to the rules of the Academy of Human Reproduction,
the 15th World Congress on Human Reproduction, will be organized in the magnificent scenario of Venice, from 13th to 16th March
2013.
The Conference will develop all the aspects of Human Reproduction, from adolescence to fertile life, pregnancy, menopause and
aging both in female and male.
The major chapters of Reproductive Pathology such Polycystic
Ovary, Endometriosis, Cronic Pelvic Pain, Abnormal Uterine Bleeding, Breast Cancer, Primary Ovarian Insufficiency and Hypogonadism in male will be discussed.
Major attention will be also dedicated to surgery and fertility, sexuality, medically assisted procreation, ovulation, implantation and to
the important areas of prenatal diagnosis, high risk pregnancy.
Furthermore, the fertility preservation in cancer women undergoing chemotherapy and the ethical aspects in reproduction will be
discussed.
The Congress will also be enriched by “meet the expert sessions”,
discussing topics such as Adenomyosis and the atypical issues in
pelvic ultrasounds.
Venice has always been the bridge between Orient and Occident,
exchanging culture and commerce. What better place than Venice
for an ethical debate stating the point of view of Islamic, Jewish
and Catholic Community, all well represented in Venice?
The Congress location of the Hilton Molino Stucky Hotel on
Giudecca Island gives us the possibility to quietly enjoy all the
Congress Sessions, while the vaporetto easily takes us to Venice
Center to enjoy the beauty of this unique city.
I very much look forward to meet you all in Venice.
3
S
Scientific Programme
Opening Lecture
Tilly Jonathan L. (USA) Ovarian Aging: Can science turn back the clock?
Plenary Lectures
Naftolin Frederick (USA) Tribalism and Reproduction in our Post-Darwinian
Society
Sciarra John J. (USA) Alternatives to hysterectomy
Donnez Jacques (B) From cryopreservation of ovarian tissue to artificial ovary.
Schenker Joseph (IL) Complications of Assisted Reproductive Technologies
Christiansen Claus (CH) Women’s health, past, present and future
Korach Kenneth (USA) Novel Role of ER Signaling in Fertility and Embryo
Development
Milewicz Andrzej (PL) Vit D and sex hormones in women and men
Plenary Sessions
ADOLESCENCE
Bruni Vincenzina (I) The diagnosis of genital malformations in adolescents
Berga Sarah (USA) Diagnosis and Treatment of Adolescent Oligomenorrhea
Sultan Charles (F) The XY adolescent female: more frequent than we imagine
Creatsas George (GR) Contraception and sexually transmitted disease during
adolescence
PROGESTINS AND ANTIPROGESTINS
Bouchard Philippe (F) Mechanisms and Classifications of Progestins, with a
special emphasis on Contraception
Schindler Adolf (D) Progestogens and hemostasis
Sitruk-Ware Regine (USA) Ulipristal long-term effects on endometrial and
breast cells
Ruan Xiangyan (ROC) Different action of progestins via membrane-bound
progesterone receptor 1
PCOS
Strauss III Jerome F. (USA) Update on Genetic Factors Contributing to PCOS
Genazzani Alessandro D. (I) PCOS as a metabolic impaired disease
Tarlatzis Basil (GR) Infertility treatment in women with PCOS
Gurgan Timur (TR) Can IVM ever replace IVF in PCOS patients?
ENDOMETRIOSIS UP TO DATE FROM DIAGNOSIS TO THERAPIES
Tinneberg Hans (D) Endometriosis: classification and diagnosis
Petraglia Felice (I) The Medical treatments
Chapron Charles (F) Endometriosis: the surgical management.
Ebert Andreas D. (D) Radical surgery in Deep Infiltrating Endometriosis –
Complications…and pregnancies
CHRONIC PELVIC PAIN AND COMORBILITIES:
Graziottin Alessandra (I) Mastcell, chronic inflammation, pain and depression
Stanghellini Vincenzo (I) Chronic Pelvic Pain and gastrointestinal Comorbilities
Bornstein Jacob (IL) Local Provoked Vulvodynia (Vestibulitis) Hyperinnervation
associated with mast cell activation –
SURGERY AND FERTILITY:
Gomel Victor (CDN) The Fallopian Tube: a reappraisal
Mettler Liselotte (D) Pros and cons for myoma enucleation in infertility surgery
Angioni Stefano (I) Fertility preserving surgery of endometrioma
Cela Vito (I) Robotic Surgery innovation: single site
4
MENOPAUSE
Stevenson John C. (UK) HRT and coronary heart disease: cause or cure
Castelo Branco Camil (E) Aging and the immune response
Genazzani Andrea R. (I) Menopausal symptoms as comorbidity factors for
brain aging
Christiansen Claus (CH) What is new in treatment of Osteoarthritis?
SEXUALITY
Palacios Santiago (E) Role of SERMs and SPERMs in female sexuality
Nappi Rossella (I) Unconfortable conversation on sexual issues at menopause
Panay Nick (UK) Testosterone: HSDD and cardiovascular impact
BREAST
Biglia Nicoletta (I) Breast cancer in young women
Gompel Anne (F) BRCA1 mutated normal breast tissue.
Simoncini Tommaso (I) Hormonal control of breast cancer metastasis
Lachowsky Michele (F) Breast cancer and sexuality
OVULATION: DIFFERENT PATIENT, DIFFERENT APPROACH
Fauser Bart C. (NL) Female health implications of PCOS
Devoto Luigi (RCH) Luteal phase dysfunction associated with ovarian
stimulation
Ferraretti Anna P. (I) Poor Ovarian Responders in ART: definition, prevalence
and prognosis
Diedrich Klaus (D) Fertility preservation in oncology
PRIMARY OVARIAN INSUFFICIENCY
Panay Nick (UK) Primary ovarian insufficiency - evolution of a global database
Vujovic Svetlana (SRB) EMAS position statement on the premature ovarian
failure
Barri Pedro (E) Reproductive options of POF patients
Mueck Alfred (D) HRT after ovarian cancer?
IMPLANTATION
Simon Carlos (E) Genomics and Secretomic of Endometrial Receptivity.
Clinical Translation
Foidart Jean Michel (B) Follicular G-CSF ,a predictive marker of embryo
competence and implantation, a useful test for embryo selection
Ben Rafael Zion (IL) Can we improve decrease ovarian reserve by better
stimulation?
Buchholz Tina (D) Trophectoderm analysis for chromosomal aberrations
OOCYTE
Patrizio Pasquale (USA) New tools to assess oocyte competence
Tan Seang Lin (CDN) IVM Treatment for difficult patients
Artini Paolo G. (I) Maintenance of biological competence after oocyte
vitrification
Veiga Anna (E) Pluripotent stem cells and regenerative medicine
MEDICALLY ASSISTED PROCREATION
Laufer Neri (IL) The association between delayed natural fertility and longevity
Kovacs Gabor T. (AUS) Gender selection for social reasons. Should it be
prohibited?
Shoham Zeev (IL) Practice vs. Science
Schmutzler Andrea (D) Polar Body Screening with FISH and Chips
PRENATAL DIAGNOSIS
Gianaroli Luca (I) PGD: preimplantation diagnosis
Nicolaides Kypros (UK) Diagnosis first trimester
Kurjak Asim (HR) Diagnosis and management of fetal abnormalities - what is
the role of 3D sonography?
Luchi Carlo (I) Change to the future: new perspectives in fetal cardiac surgery
HIGH RISK PREGNANCY
Lyall Fiona (UK) Mechanisms underlying placental dysfunction in preeclampsia
Ferrazzi Enrico (I) Metabolomics and the biophysical indices of the fetus with
chronic and acute hypoxia
Russel J. Reiter (Usa) Placental melatonin: Function as an antioxidant in the
fetus and mother
Brincat Mark (M) Progesterone & Progestogens in the prevention
of Premature Labour
THE UNMET NEEDS IN MATERNAL-FETAL MEDICINE
Facchinetti Fabio (I) Pitfalls in preterm delivery prevention Visser Gerard H. (NL) Women are designed to deliver vaginally: is that really true?
Regan Leslie (UK) Poor trophoblast invasion – key determinants
Carp Howard (IL) Progestogens in threatened miscarriage
CONTRACEPTION
Skouby Sven O. (DK) Long acting reversible contraceptives (LARC) New
horizons
Sitruk-Ware Regine (USA) A vaginal ring to deliver PRMs for contraception
Serfaty David (F) Emergency contraception: ulipristal acetate or levonorgestrel?
Siseles Nestor (ARG) What is the impact of the use of contraceptive methods
on the health in the menopausal transition?
THE HYPOGONADAL MALE:
Nieschlag Eberhard (D) The Klinefelter syndrome
Christin-Maitre Sophie (F) Hypogonadism in male: what etiologies should we
think about?
Lunenfeld Bruno (IL) Male aging- clinical consequences and management
Huszar Gabor (USA) Sperm-hyaluronic acid binding score and assessment of
sperm development: sperm ha-binding, total motile sperm and age attributes in
768 men
ABNORMAL UTERINE BLEEDING
Hamou Jacques (F) Contribution of diagnostic and operative hysteroscopy
prior to IVF
Goldstein Steven R. (USA) Endometrial evaluation in perimenopausal women
Gambacciani Marco (I) From hormone therapy to minimally invasive surgery
Kiesel Ludwig (D) Chemotherapy-induced amenorrhea
FERTILITY PRESERVATION IN CANCER WOMEN UNDERGOING
CHEMOTHERAPY
Gadducci Angiolo (I) Potential effect of chemotherapy on future fertility
Treves Rachel (F) Psychological and ethical impacts of fertility preservation in
cancer women
Cobo Ana (E) Oocyte cryopreservation for cancer patients
Almeida Santos Ana Teresa (P) Fertility preservation in breast cancer patients
HORMONAL CONTRACEPTION: FUTURE AND NEW OPTIONS
Coelingh Bennink Herjan J.t. (NL) Clinical effects of repairing the loss of
testosterone caused by the pill
De Melo Nilson R. (BR) Future of hormonal contraception
Khomassuridze Archil (GE) Noncontraceptive Possibilities of Hormonal
Contraceptives
ART: FROM BASIC SCIENCE TO CLINICAL APPLICATION
Coutifaris Christos (USA) Singletons and ART: what does the science tell us?
Buehler Klaus (D) LH supplementation - only in older women?
Seppala Markku T. (FIN) Glycoprotein glycosylation: Significance in
fertilization, fetomaternal defence, and gestational diabetes
Beier Henning M. (D) Essential parameters of endometrial receptivity:
Uteroglobin and related proteins
Meet the expert sessions
ADENOMYOSIS
Benagiano Giuseppe (I) Adenomyosis and infertility
Hamou Jacques (F) Hysteroscopy treatment of adenomyosis in infertility
PELVIC ULTRASOUNDS: THE ATIPICAL ISSUES
Exacoustos Caterina (I) 3D ultrasound evaluation of the uterine junctionale
zone in pelvic endometriosis and infertility
Goldstein Steven R. (USA) Incidental findings on Pelvic Ultrasound: How to
handle them
SUBTOTAL VERSUS TOTAL HYSTERECTOMY
Mettler Liselotte (D)
Ussia Anastasia (I)
NEW HORIZONS IN IVF GENETIC DIAGNOSIS
Schmutzler Andreas (D)
Horcajadas José (E)
Special Session
ETHICAL ASPECTS IN REPRODUCTION
Schenker Joseph (IL) Jewish Perspectives
Serour Gamal (ET) Islamic Perspectives
Huber Johannes (A) Catholic Perspectives
Birkhaueser Martin (CH) Protestant Perspectives
Symposia by scientific society
POLISH SOCIETY OF GYNECOLOGICAL ENDOCRINOLOGY
Breborowicz Grzegorz H. (PL) Value of proegesterone supplementation in
early pregnancy
Katulski Krzysztof (PL) Pregnancy complications in PCOS patients
Meczekalski Blazej (PL) What do we actually know about ovarian ageing?
Milewicz Andrzej (PL) Serum sex hormones levels in Ageing Polish Population
and Cardiovascular Risk Factor-PolSenior Study
Wicherek Lukasz (PL) The use of neoadjuvant chemotherapy and less radical
resection in cervical carcinoma as a way to preserve fertility
FISS - SALUTE SESSUALE E SALUTE RIPRODUTTIVA
Fabrizi Adele (I) La sessualità nella donna infertile
Stettini Piero (I) Sessualità e infertilità...infertilità e sessualità
Todella Roberto (I) La valutazione sessuologica della coppia in cerca
di gravidanza
SOBRAGE Symposium - Highlights in Gynecological Endocrinology
Maia Hugo Jr.(BR) Natural NF-Kappa.b inhibitors associated with continuous
oral contraceptives for the treatment of endometriosis
Bonassi Rogerio (BR) Clinical trials with extended regimens of oral
contraceptives: the Brazilian experience
Magalhães Jarbas (BR) Intrauterine system with levonorgestrel for the
treatment of menorrhagia
Maia Hugo Jr.(BR) Androgen replacement in late menopause and its impact
on inflammatory markers.
Pellini Eliano (BR) Menopause is far from being the sunset of sexuality
Casoy Julio (BR) Concluding remarks.
ISGE - International Society of Gynecological Endocrinology
IMS - International Menopause Society
SEG - European Society of Gynecology
MSRM - Mediterranean Society For Reproductive Medicine
MENOPAUSE: NEW CHALLENGES, NEW SOLUTIONS
Studd John (UK) Should oestrogens be first choice therapy for osteoporosis in
the under 60’s ?
Marie Scemama Lydia (F) Menopause, Drugs and Doctors today
Panay Nick (UK) HRT: How to solve the progestogen problem?
Pluchino Nicola (I) Estetrol: a fetal estrogen with many opportunities: the CNS
impact
5
F
PS-SY
Plenary Session - Symposium
PL
Plenary Lecture
MTE
Meet the Expert
SS-OP
Scientific Society Symposium - Oral Presentations
LS
Lunch Symposium
format of the congress
Halls
Venice 1
350 pax
Venice 2
350 pax
Venice 3
350 pax
Goldoni
120 pax
80 pax
Casanova
Wednesday March 13th
09.00-13.00
14.00-16.00 Opening Symposium
16.30-17.15 Opening Ceremony
17.15-18.00 Opening Lecture
18.00-20.00 Poster Session and Get Together
Thursday, March 14th
08.30-09.30 SS-OP
MTE
SS-OP
MTE
SS-OP
09.45-11.15 PS-SY
PS-SY
PS-SY
PS-SY
SS-OP
PS-SY
PS-SY
SS-OP
11.15-11.45 Exhibition Area and Coffee
11.45-13.15 PS-SY
PS-SY
13.15-15.15 LS
LS
15.15-15.45 Exhibition Area and Coffee
15.45-16.15 PL
PL
16.30-18.00 PS-SY-RT
PS-SY-RT
Italian Teaching
Course
PL
PS-SY-RT
SS-OP
Friday, March 15th
08.30-09.30 SS-OP
MTE
SS-OP
MTE
SS-OP
09.45-11.15 PS-SY
PS-SY
PS-SY
PS-SY
SS-OP
PS-SY
PS-SY
SS-OP
11.15-11.45 Exhibition Area and Coffee
11.45-13.15 PS-SY
PS-SY
13.15-15.15 LS
LS
15.15-15.45 Exhibition Area and Coffee
Italian Teaching
Course
15.45-16.15 PL
PL
16.30-18.00 PS-SY
PS-SY
Saturday March 16th
08.15-09.15 SS-OP
MTE
SS-OP
09.30-11.00 PS-SY
PS-SY
PS-SY
PL
PS-SY
SS-OP
MTE
SS-OP
SS-OP
11.00-11.30 Exhibition Area and Coffee
11.30-13.00 PS-SY
PS-SY
13.00-15.00 SPECIAL SESS.
SPECIAL SESS.
PS-SY
PS-SY
SS-OP
15.00-15.30 Exhibition Area and Coffee
15.30-16.00 PL
PL
PL
PL
16.00-17.30 PS-SY
PS-SY
PS-SY
PS-SY
17.30-18.00
6
Closing Cerem.
SS-OP
F
FEES
Registration Fees
Registration fees* 21% VAT INCLUDED
Until 26/10/2012
Until 18/01/2013
After 18/01/2013
Delegate
€ 500,00
€ 650,00
€ 750,00
Delegate (from Developing Countries WHO list)
€ 400,00
€ 550,00
€ 650,00
Residents, nurses and technicians
(status to be certified)
€ 300,00
€ 400,00
€ 500,00
Accompanying person
€ 150,00
€ 150,00
€ 150,00
Registration Fee
for the Delegate includes:
Registration Fee
for accompanying persons includes:
•
•
•
•
•
•
• Opening Ceremony
• Closing Ceremony
• Half-day Venice City Tour
Opening Ceremony
Closing Ceremony
Access to all sessions and exhibition area
Congress kit
Abstract Book/CD
CME credits
How to register
Registration is only possible online filling out the
registration form on the website
www.humanrep2013.com
Group registration
If you are interested in a group registration (10
persons or more), please email the Congress Secretariat at [email protected] for further
information. Please note that no registration will be
made without full personal contact details for each
participant. Blank registrations are not allowed.
Rialto
Museum
A
Accommodation
Accommodation
By booking one of ourRialto
hotels you can have:
•
Breakfast
included
For your convenience, the CongressBasilica
Organizers
di S. Marco
have reserved hotel rooms at various price levels and • Discounted and guaranteed rates;
• Custom Payment methods choosing between
a great selection of standards.
booking by deposit or by full payment;
If you book the hotel through our system you can
•
Payment by credit card through safe connection
choose from the best hotels in Venice close to the
system.
Congress Venue carefully selected by our Organi•
If, in case of “force majeure” the congress is
zation.
moved to later date, your reservation will be
guaranteed
by the Organization;
Basilica
di S. Marco
Peggy Guggenheim Museum
cky
*Cancellation policy for registration
Refunds (less € 25,00 for taxes and administrative
expenses) will be granted to delegates unable to
attend. A written notice must be received by the
Organizing Secretariat before January 15th, 2013.
No refunds will be made for cancellations received
after January 15th, 2013. All refunds will be issued
after the Congress.
Insurance
The Congress Organizers will not accept any liability for personal injury, or loss/damage to property or
belongings of participants or accompanying persons,
either during or as a result of the Congress during
their stay in Venice. It is, therefore, recommended
that participants arrange their own personal health,
accident and travel insurance.
7
www.humanrep2013.com
the congress is supported by
8

Similar documents

Stefano Berti - parentesiquadre

Stefano Berti - parentesiquadre Access to all sessions and exhibition area Congress kit Abstract Book/CD CME credits

More information